Previous 10 | Next 10 |
Takeda Enters Into Two-Year Contract with Canadian Blood Services for GLASSIA®, Treatment for Rare form of Emphysema Canada NewsWire Availability of GLASSIA ® represents significant milestone for patients with emphysema due to severe hereditary defic...
2023-12-18 11:24:00 ET Summary Wave Life Sciences Ltd. raised $100 million in a discounted public offering, causing a decline in their stock price. The market reaction may have been incorrect, as the company has positive proof of concept data and major partnerships with Takeda and...
If Approved, HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] Would Offer an up to Once-Monthly Facilitated Subcutaneous At-Home or In-Office Treatment Option Positive Opinion Based on Phase 3 ADVANCE-CIDP 1 Study, Which Met its Primary Endpoint D...
2023-12-14 02:41:45 ET Japan ( NKY:IND ) -0.73%. Japan data: October Industrial Production (final) +1.3% (prior +0.5%). Japan October Machinery orders +0.7% m/m (vs. expected -0.5%). Markets also turned cautious ahead of the Bank of Japan’s policy meetin...
2023-12-13 02:47:25 ET More on Asia Tactical Investment System For S&P 500 - Financial Stress Index (Part 4) Asian markets mixed as investors await U.S. inflation numbers For further details see: Asian markets mixed as investors remain cautious ahead of Fed d...
2023-12-12 13:17:41 ET More on Johnson & Johnson Johnson & Johnson Vs. Pfizer: Better Pharma Stock? Stocks To Watch: Big Week On Tap For McDonald's, Shopify, GameStop, And Johnson & Johnson Johnson & Johnson: Sleep Well At Night With The Only AAA-Rate...
2023-12-12 03:49:29 ET Summary Today, we take a deeper look at Denali Therapeutics, a biotech company focused on developing treatments for neurodegenerative and lysosomal storage diseases. Denali's developmental focus has drawn several collaboration partnerships from much larger d...
2023-12-12 02:45:02 ET More on Asia Bank of Japan: Last Man Standing With Negative Interest Rate Policy - May End Soon BOJ talk fuels bets on Japan exiting negative rate policy this month For further details see: Asian markets mixed as investors await U.S. inflat...
2023-12-11 15:41:33 ET Summary BioCryst faces heightened competition in the HAE market due to Pharvaris' positive CHAPTER-1 study of deucrictibant. Despite strong Q3 2023 revenues, BioCryst's long-term debts cast a shadow over its financial stability. The market reacted to Pha...
2023-12-11 11:40:56 ET More on Seattle Genetics, Takeda Pharmaceutical, etc. Takeda Pharmaceutical Company Limited (TAK) Q2 2023 Earnings Call Transcript Seagen's Acquisition: EU Approval And Potential Upside Takeda: Why I'm Staying Bearish On This Generic Drug Divid...
News, Short Squeeze, Breakout and More Instantly...
Takeda Pharmaceutical Company Limited American Depositary Shares Company Name:
TAK Stock Symbol:
NYSE Market:
Takeda Pharmaceutical Company Limited American Depositary Shares Website:
2024-07-18 10:20:00 ET July 18, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at biotech/biopharma stocks, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:CTXR ), a late-stage biopharmaceutical compa...
2024-07-04 20:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Takeda (TOKYO:4502/NYSE:TAK) has announced new assignments of directors, determined at the Board of Directors meeting and at the Audit and Supervisory Committee meeting, following the 148th Ordinary Meeting of Shareholders, held in Osaka today. Takeda's Board of Directors has 11 members servi...